Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

OMIC | Singular Genomics Systems Inc

Index- P/E- EPS (ttm)-1.31 Insider Own44.59% Shs Outstand71.85M Perf Week-6.93%
Market Cap27.09M Forward P/E- EPS next Y-1.28 Insider Trans-1.40% Shs Float40.52M Perf Month-20.48%
Income-94.10M PEG- EPS next Q-0.38 Inst Own34.63% Short Float / Ratio2.38% / 4.29 Perf Quarter-53.11%
Sales2.13M P/S12.72 EPS this Y-10.28% Inst Trans2.32% Short Interest0.97M Perf Half Y-69.64%
Book/sh2.99 P/B0.12 EPS next Y9.14% ROA-28.94% Target Price0.95 Perf Year-85.18%
Cash/sh2.83 P/C0.13 EPS next 5Y11.10% ROE-36.48% 52W Range0.34 - 3.00 Perf YTD-81.57%
Dividend- P/FCF- EPS past 5Y- ROI-34.96% 52W High-87.65% Beta0.97
Dividend %- Quick Ratio15.15 Sales past 5Y0.00% Gross Margin-335.07% 52W Low8.62% ATR0.03
Employees275 Current Ratio16.18 Sales Q/Q- Oper. Margin-4608.77% RSI (14)29.79 Volatility7.25% 7.45%
OptionableYes Debt/Eq0.27 EPS Q/Q-4.13% Profit Margin-4411.72% Rel Volume0.51 Prev Close0.36
ShortableYes LT Debt/Eq0.23 EarningsAug 09 AMC Payout- Avg Volume225.24K Price0.37
Recom2.33 SMA20-8.08% SMA50-29.87% SMA200-70.38% Volume115,809 Change3.99%
Date Action Analyst Rating Change Price Target Change
Aug-17-22Downgrade UBS Buy → Neutral $10 → $4.50
Aug-10-22Downgrade Goldman Buy → Neutral $3.50
Aug-10-22Downgrade BofA Securities Buy → Underperform $3
Jan-07-22Upgrade BofA Securities Neutral → Buy $21
Oct-15-21Resumed Cowen Outperform
Sep-20-23 11:28AM
Sep-08-23 08:00AM
Aug-10-23 12:27PM
Aug-09-23 04:46PM
04:05PM Loading…
Aug-08-23 04:05PM
Aug-02-23 04:05PM
Jul-26-23 04:05PM
Jun-01-23 04:05PM
May-11-23 06:38AM
May-10-23 09:45AM
May-09-23 04:21PM
Apr-25-23 04:05PM
Mar-06-23 05:51AM
07:30AM Loading…
Mar-03-23 07:30AM
Mar-02-23 04:22PM
Feb-23-23 04:05PM
Feb-16-23 04:05PM
Feb-06-23 07:00AM
Feb-02-23 08:00AM
Jan-25-23 05:05AM
Jan-09-23 06:00AM
Dec-21-22 04:05PM
Dec-15-22 05:14AM
Nov-28-22 05:11AM
Nov-07-22 04:01PM
Oct-24-22 04:05PM
04:05PM Loading…
Aug-25-22 04:05PM
Aug-18-22 04:05PM
Aug-14-22 10:49AM
Aug-10-22 05:00AM
Aug-09-22 04:01PM
Aug-08-22 04:30PM
Aug-02-22 07:30AM
Jul-28-22 04:06PM
Jun-20-22 10:22AM
Jun-07-22 08:00AM
Jun-06-22 04:05PM
Jun-03-22 08:00AM
May-21-22 08:00AM
May-10-22 04:05PM
May-05-22 08:40AM
Apr-26-22 04:15PM
Mar-07-22 12:54PM
Mar-02-22 11:30PM
Mar-01-22 08:00AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Jan-18-22 10:11AM
Jan-10-22 07:30AM
Jan-07-22 08:00AM
Jan-06-22 04:05PM
Dec-27-21 11:38PM
Dec-16-21 07:30AM
Nov-29-21 10:17AM
Nov-11-21 05:30AM
Nov-09-21 04:05PM
Oct-28-21 04:05PM
Aug-27-21 10:38AM
Aug-05-21 07:30AM
Aug-03-21 06:05AM
Jun-22-21 10:16AM
Jun-01-21 04:05PM
May-26-21 11:56PM
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kamdar Kim P.DirectorAug 15Sale0.53200,000106,9603,763,985Aug 15 07:17 PM
Kamdar Kim P.DirectorAug 14Sale0.5777,99144,4243,963,985Aug 15 07:17 PM
Kamdar Kim P.DirectorAug 11Sale0.60353,657210,6034,041,976Aug 15 07:17 PM
Glezer Eli N.Chief Scientific OfficerMay 17Buy0.82170,000138,9244,355,000May 18 08:32 PM
Glezer Eli N.Chief Scientific OfficerDec 12Buy2.0050,000100,0004,185,000Dec 13 06:14 PM